Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy and adolescents.

A Verrotti1, G Di Corcia, G Morgese

  • 1Department of Medicine, Section of Pediatrics, University of Chieti, Ospedale Policlinico, Via dei Vestini 5, 66100 Chieti, Italy. averrott@obelix.unich.it

Panminerva Medica
|June 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FBXW7-Related Neurodevelopmental Disorder: Clinical Spectrum, Molecular Mechanisms, and Tumor Predisposition.

Human mutation·2026
Same author

Effects of anti-epileptic drugs on the oral health of paediatric patients.

European journal of paediatric dentistry·2023
Same author

COVID-19 and abdominal pain: a pediatric case report and a point of view in pediatric emergency medicine.

European review for medical and pharmacological sciences·2021
Same author

Carotid intima media-thickness is increased in obese children metabolically healthy, metabolically unhealthy, and with metabolic syndrome, compared to the non-obese controls.

European review for medical and pharmacological sciences·2021
Same author

Epidemiology and drug allergy results in children investigated in allergy unit of a tertiary-care paediatric hospital setting.

Italian journal of pediatrics·2020
Same author

A validation study of the clinical diagnosis of Dup15q syndrome: Which symptoms matter most?

Seizure·2019
Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026
Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026
Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026
See all related articles

Adolescent anticonvulsant (AEDs) therapy poses challenges due to poor adherence. Factors like motivation, treatment outcomes, and support systems influence compliance, while AEDs can cause endocrine and weight abnormalities.

Area of Science:

  • Pediatric Endocrinology
  • Neuropharmacology

Background:

  • Adolescent anticonvulsant (AEDs) therapy is complicated by adherence issues.
  • Factors influencing compliance include motivation, therapeutic success, and support systems.

Purpose of the Study:

  • To review endocrinological and weight changes associated with AEDs in adolescents.
  • To highlight potential endocrine disruptions, including thyroid function, from specific AEDs.

Main Methods:

  • Literature review of studies on AEDs in adolescent populations.
  • Analysis of reported endocrinological and weight-related side effects.

Main Results:

  • AEDs can lead to weight gain or loss, polycystic ovarian syndrome, and bone diseases.

Related Experiment Videos

  • Carbamazepine (CBZ) and valproate (VPA) are associated with endocrine changes, including potential subclinical hypothyroidism.

    • Conclusions:

    • AED therapy in adolescents requires careful monitoring for endocrine and metabolic side effects.
    • Combined therapy, such as CBZ with VPA, may exacerbate thyroid abnormalities.